No Counsel, No Lawsuit: Federal Court Tosses CBD Trade Secret Case

SS
Seyfarth Shaw LLP

Contributor

With more than 900 lawyers across 18 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
As we previously reported, CBD company Healthcare Resources Management Group, LLC (Healthcare Resources) filed an action in the US District Court for the Southern District of Florida...
United States Intellectual Property

As we previously reported, CBD company Healthcare Resources Management Group, LLC (Healthcare Resources) filed an action in the US District Court for the Southern District of Florida claiming trade secret misappropriation by Medterra CBD and EcoNatura, and alleging that Medterra CBD and EcoNatura worked together to manufacture and sell a CBD cream using Healthcare Resources' proprietary formula. On February 18, 2020, the defendants moved to dismiss the case on the grounds that Healthcare Resource failed to allege that it had provided or that Medterra had otherwise acquired any proprietary information. Healthcare Resources responded arguing that its trade secret claim is legitimate so long as (1) there was improper use of proprietary information; and (2) that use was enabled by a party who had a duty to guard and limit the use of such proprietary information. The case has now been dismissed, but not for any of the reasons the parties briefed. Rather, in a May 21, 2020, order, Judge Donald Middlebrooks dismissed the suit without prejudice for failing to secure counsel to represent it in the case and denied Healthcare Resources' pro se request for additional time to obtain new counsel.

Healthcare Resources' recent woes began when its counsel withdrew in late April 2020. Given plaintiff's status as an artificial entity (an LLC), Judge Middlebrooks provided it 21-days to secure replacement counsel. On the day of the deadline, Healthcare Resources, through its managing member, filed a motion seeking additional time to secure new counsel on a pro se basis, arguing that it could not find new counsel because of the disruptions caused by COVID-19.

Judge Middlebrooks denied the motion and dismissed the suit on multiple grounds. First, Healthcare Resources is an artificial entity, and as such it cannot proceed without counsel. Second, on procedural grounds, plaintiff had failed to meet and confer with defendants prior to filing its motion, thereby violating local rules. Third and most critically, Healthcare Resources failed to adhere to deadlines imposed by the court and to work diligently to secure new counsel. The court noted that plaintiff's managing member had failed to establish, specifically, what measures he took to find new counsel. In reaching its decision, the court also cited defendant MedTerra's argument that any extension would be prejudicial to defendants.

The upshot of this decision is that companies looking to protect their trade secrets should select counsel wisely and act diligently when ordered to do so by a court, or risk having their case dismissed. As noted, the case was dismissed without prejudice, so we will continue to monitor it and will report back if Healthcare Resources is able to secure new counsel and file a new complaint.

Originally published 28 May, 2020

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More